Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

Overview of attention for article published in New England Journal of Medicine, March 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 26 news outlets
blogs: 8 blogs
policy: 3 policy sources
twitter: 63 X users
patent: 10 patents
facebook: 10 Facebook pages

wikipedia: 1 Wikipedia page
googleplus: 1 Google+ user
reddit: 5 Redditors
f1000: 1 research highlight platform
guideline: 17 clinical guideline sources

Readers on

mendeley: 973 Mendeley

So far, Altmetric has seen 37 Guidelines that reference this research output.

Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society (NSFA) and the French Society of Cardiology (SFC)

Clinical guideline published by Société Française d'Endocrinologie (SFE) on 06 Feb 2026

The Société Française d'Endocrinologie (SFE) is dedicated to advancing knowledge in endocrinology, diabetes, and metabolic diseases. It offers resources such as clinical guidelines, expert debates, and educational events to support healthcare professionals in delivering optimal patient care.

Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society (NSFA) and the French Society of Cardiology (SFC)

Clinical guideline published by Société Française d'Endocrinologie (SFE) on 06 Feb 2026

Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Society of Atherosclerosis (NSFA) and the French Society of Cardiology (SFC)

Clinical guideline published by Société Française d'Endocrinologie (SFE) on 19 Nov 2025

Tratamiento de dislipidemias en el adulto

Clinical guideline published by Centro Nacional de Excelencia Tecnológica en Salud (CENETEC) on 01 Jan 2022

CENETEC provides information based on the best available evidence for appropriate decision-making in health technologies in health services in Mexico.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 33 additional posts.